Simlukafusp alfa - CAS 1776942-10-9

Simlukafusp alfa (FAP-IL2v) is a tumor-targeting immune cytokine, a human IgG1 antibody, with antitumor activity and immunostimulatory properties that potentiate in vitro and in vivo activity of therapeutic antibodies mediating antibody-dependent or T-cell-independent cytotoxicity (TDCC) and programmed death ligand 1 (PD-L1) checkpoint inhibition.

Interleukin

Immunology/Inflammation

1776923

0.973

-20°C

Ice Packs

Inhibitory Antibodies